>> AND SOMEONE WHO’S BEEN IN THE BUSINESS FOR A LONG TIME THIS IS JUST
UNBELIEVABLE IT’S YOU KNOW I
SAY SCIENCE IS THE HERO HERE IN
MARCH OF 2020 THE WORLD
HEALTH ORGANIZATION DECLARED
COVID-19 A PANDEMIC AND IN THE
19 MONTHS SINCE.
>> THE WORLD
HAS CHANGED.
>> THE SOCIAL DISTANCING
SHUTDOWNS BARS AND OTHER
NON-ESSENTIAL BUSINESSES IN SAN
ANTONIO WILL HAVE TO SHUT DOWN
THIS VIDEO SHOWS THOUSANDS OF
FAMILIES IN
THEIR CARS, LINING UP TO
RECEIVE THROUGH IT ALL SCIENCE
HAS
PROVIDED HOPE.
>> FROM A RESEARCH PERSPECTIVE
ALL TARGETING AND ALSO KUZMA TO
COVID RESEARCH. >> AND RIGHTFULLY SO IN THE FORM OF TREATMENTS AND
EVENTUALLY VACCINES IT WAS
INCREDIBLY FAST.
>> WHICH WAS NECESSARY. GIVEN
THE CHALLENGES THAT WE HAVE AND
NOT NORMAL
AND SOME OF THAT GROUNDBREAKING
RESEARCH DONE RIGHT HERE IN SAN
ANTONIO.
>> WE HAD IN TESTING OF
VACCINES THAT HAVING GIVEN TO A
BILLION PEOPLE WORLDWIDE IN
MONKEYS LAST YEAR AND WE HAVE
TO INVEST IN AUSTIN A FEW TICKS
AND DOCTORS GIVING PEOPLE I’M
PROUD OF THIS AND COMING IN
THAT WE HAVE TO FEEL ABOUT THAT
HERE IT DOES SUCH A
GROUNDBREAKING RESEARCH IS
IMPACTING LIVES OVER THE WORLD.
>> IN THIS EPISODE OF KSAT EXPLAINS WE’RE INTRODUCING YOU TO SOME OF THE SAN ANTONIO
SCIENTIST WHO ARE BEHIND
CRUCIAL COVID-19 RESEARCH FROM
THE BEGINNING OF
THIS PANDEMIC THEY WALK US
THROUGH HOW COVID HAS AFFECTED
THEIR WORK. THE INCREDIBLE
SCIENTIFIC BREAKTHROUGHS WE’VE
WITNESSED AND HELP THOSE
BREAKTHROUGHS COULD HELP US
WITH FUTURE VIRUSES AND
DISEASES.
>> THE SHAKING DURING THE PANDEMIC AND THE BATTLE. ♪
♪
♪ ♪ OUR CITY. AN EXAMINATION OF
WHAT IT MEANS TO BE BLACK.
♪
THIS WEEK THE TEAM IS SPOTLIGHTING SOME OF THAT GROUNDBREAKING WORK A LOCAL
SCIENTIST DO IT.
>> THANKS FOR JOINING US FOR THIS EPISODE OF KSAT EXPLAINS I’M MYRA ARTHUR SINCE
EARLY 2020 THE COVID-19
PANDEMIC HAS ALTERED NEARLY
EVERY ASPECT OF
OUR LIVES. THE SHUTDOWNS THE
JOB LOSSES, THE MILLIONS OF
DEATHS GLOBALLY IT’S DIFFICULT
TO PUT INTO WORDS JUST HOW MUCH
HAS BEEN FOREVER CHANGED AND
HOW MUCH SO MANY
OF LOST. WE’VE COVERED SO MANY
OF THE STORIES ON KSAT 12 US
ROLLS RIGHT HERE ON THIS SHOW
AND WILL CONTINUE TO DO SO.
BUT FOR THIS EPISODE WE WANT TO
FOCUS ON SOMETHING INCREDIBLE
THAT HAS COME OUT OF
THIS PANDEMIC THE SCIENTIFIC
RESEARCH THAT’S OFFERED US HOPE
THROUGH IT ALL
AND DID YOU KNOW THAT A BIG
PART OF THAT RESEARCH HAS
HAPPENED RIGHT HERE IN OUR OWN
BACKYARD. AT TEXAS BIOMEDICAL
RESEARCH INSTITUTE. SCIENTISTS
THERE TOLD US THAT AS THE REST
OF THE WORLD SLOWDOWN THEIR
WORK WAS SPEEDING UP.
>> FASCINATING IN A WAY AND
ALSO YOU KNOW REALLY WORRYING
THAT TELL DOCTOR JOANNE TURNER
DESCRIBES WATCHING NEWS ABOUT
THE NOVEL CORONAVIRUS PLAY OUT
IN REAL TIME IN EARLY
2020.
>> AS TEXAS BIOMED VICE
PRESIDENT OF RESEARCH AND A
SCIENTIST WITH AN ACTIVE
RESEARCH PROGRAM AND
TUBERCULOSIS TURNER KNOWS A LOT
ABOUT
INFECTIOUS DISEASE.
>> ANYONE THAT INFECTIOUS
DISEASES NOTICED THAT THERE IS
LIKELY TO BE A GLOBAL PANDEMIC
BUT STILL JUST LIKE SO
MANY OF US SHE DIDN’T REALIZE
HOW SERIOUS A THREAT COVID-19
WOULD BECOME IT BECAME APPARENT
THAT IT WAS HIM AND
THE MASSIVE.
>> AND HAVE A MAJOR IMPACT ON
RESEARCH ON PEOPLE’S DAILY
LIVES ON
THE ECONOMY. WE’RE REALLY
HEADING IN SOMETHING VERY VERY
WORRYING VERY SOON.
>> AFTER THE. THE AT THE START
OF THE PANDEMIC IT BECAME CLEAR
AND THAT THIS VIRUS WAS MUCH
DIFFERENT THAN THE OTHER SARS
CORONAVIRUS THAT EMERGED
BACK IN
2003 RESEARCHERS AT TEXAS
BIOMED WERE FORCED TO SWITCH
GEARS FROM A RESEARCH
PERSPECTIVE ALL.
>> ALL.
>> ALL TARGETING AND ALSO
CUSTOM TO COVID
RESEARCH AND RIGHTFULLY SO AND
THE CITIES ACROSS THE WORLD
WERE SHUTTING DOWN THERE WAS A
GROWING SENSE OF URGENCY FELT
ACROSS THE SCIENTIFIC WORLD WE
WERE ACTUALLY ONE OF THE FEW
PLACES PREPARED FOR
THE PANDA DOCTOR LARRY
SCHLESINGER PRESIDENT AND CEO
OF TEXAS BIOMED SAYS THE
INSTITUTE WAS PREPARED. THANKS
IN PART TO A STRATEGIC PLAN
THAT WAS ADOPTED IN 2018
PART OF THAT PLAN
INCLUDED RECONSTRUCTING TEXAS
BIOMED TO WORK ON INFECTIOUS
DISEASE PREVENTION WHEN WE KNEW
THERE WAS
A PROBLEM.
>> YOU KNOW JANUARY FEBRUARY OF
2020. WE IMMEDIATELY WITHOUT ANY SILOS ARE WAS PUT THE RIGHT SCIENTISTS IN THE ROOM
THROUGHOUT THE INSTITUTE CAME
IN A
ROOM SET WE NEED TO WE NEED TO
COME IN WE NEED TO LEAN IN AND
MAKE A DIFFERENCE HERE BASED ON
OUR EXPERTISE AND OUR
RESOURCES. THE EXPERTISE HERE
IN BIOMEDICAL RESEARCH DATES
BACK
80 YEARS.
>> THE PRIVATE NOT FOR PROFIT
INSTITUTE HAS HAD A HAND IN
WORKING ON MEDICAL RESEARCH
FOR DECADES, INCLUDING THE
FIRST EBOLA TREATMENT AND THE
FIRST TREATMENT FOR HEPATITIS C
WE HAVE THE ABILITY
TO HANDLE. RESEARCH AND
DEVELOPMENT RELATED TO ANY
INFECTIOUS DISEASES.
>> BECAUSE WE HAVE TREMENDOUS
HISTORY AND EXPERIENCE RELATED
TO WHAT IS CALLED BIO
CONTAINMENT RESEARCH.
>> BIO CONTAINMENT RESEARCH IS
DONE IN BIOSAFETY LABS LABS
THAT ARE DESIGNED TO ALLOW
SCIENTISTS TO STUDY CONTAGIOUS
VIRUSES WITHOUT RELEASING THOSE
VIRUSES TO THE PUBLIC OR
INFECTING RESEARCHERS THESE
LABS ARE RANKED FROM BIOSAFETY
LEVEL ONE THROUGH 4 DEPENDING
ON THE DANGER OF THE PATHOGENS
BEING STUDIED AT EACH LEVEL.
FOR EXAMPLE BIOSAFETY LEVEL ONE
OR BSL ONE
IS FOR PATHOGENS THAT DON’T
REALLY POSE A THREAT A BIO
CONTAINMENT LEVEL ONE IS
YOUR KITCHEN BSL 2 IS FOR HUMAN
DISEASES THAT POSE A MODERATE
HAZARD LIKE
HEPATITIS VIRUSES. BSL 3 LABS
ARE USED WHEN DEALING WITH
PATHOGENS THAT MAY CAUSE
SERIOUS OR POTENTIALLY
LETHAL DISEASE THROUGH
INHALATION BIO CONTAINMENT
LEVEL 3 FACILITIES ARE
SPECIALIZED AIR.
>> CONTROLLED ENVIRONMENTS TO
CONDUCT RESEARCH. IT ON
INFECTIOUS DISEASES THAT CAN
AFFECT HUMANS BUT FOR WHICH
THERE ARE CURES
AND THEN BIOCONTAINMENT LAB
BEFORE IS THE HIGHEST
LEVEL CONTAINMENT WHERE WE WORK
ON INFECTIOUS
AGENTS SAFELY. THOSE AGENTS
LIKE EBOLA VIRUS THAT HAVE NO
CURRENT CURE IS. AND SO WE HAVE
TO DO THINGS VERY SAFE.
>> THEN THERE ARE BSL
4 LABS TEXAS BIOMED IS HOME TO
ONE OF 10 OPERATIONAL BSL 4
LABS IN THE ENTIRE COUNTRY
AND THE PRECAUTIONS RESEARCHERS
HAVE TO TAKE WHEN DOING WORK IN
THESE LABS IS SERIOUS THIS VIDEO SHOWS ONE OF THE INSTITUTE’S RESEARCHERS
PREPARING TO DO WORK AT A BSL 4
LAB. SHE’S PUTTING ON THIS AIR
SUPPLIED POSITIVE PRESSURE SUIT
TO TAKE A LOOK AT DATA RELATED
TO A STUDY ON THE
EBOLA VIRUS. THERE ARE SAFETY
PRECAUTIONS THAT RESEARCHERS
MUST TAKE WHEN ENTERING AND
EXITING. THE LAB HAS ITS OWN
VENTILATION SYSTEM AN AIR TIGHT
DOORS AND THE DATA STORED THERE
CANNOT BE REMOVED ANOTHER
RESOURCE TEXAS BIOMED HAS ON
ITS CAMPUS. THE ABILITY TO TEST
ON ANIMALS. THE INSTITUTE IS HOME TO THOUSANDS OF ANIMALS MORE THAN 2500 NON-HUMAN
PRIMATES AND ABOUT 5,000
RODENTS.
>> SCHLESINGER SAYS IT DIDN’T
TAKE SCIENTISTS AT THE FACILITY
LONG TO KNOW THEY WOULD NEED TO
DEVELOP ANIMAL MODELS FOR COVID
TO DO THAT THEY
NEEDED MONEY SCHLESINGER SAYS
THANKS TO COMMUNITY PARTNERS
AND PHILANTHROPIC SUPPORTERS.
THEY RAISED 5 MILLION DOLLARS
WITHIN A COUPLE OF WEEKS THIS
ISN’T PRECEDENT.
>> WE HAVE THE EXPERTISE WE
HAVE THAT WE THE ANIMALS AND WE
HAD THE
RESOURCES NOW.
>> FROM THEIR RESEARCH WAS ABLE
TO BEGIN SCIENTISTS TO TEXAS
BIOMEDICAL RESEARCH INSTITUTE
JOINED IN THE GLOBAL SEARCH FOR
TREATMENTS AND A VACCINE TO
TAKE ON THIS PANDEMIC
BRINA MONTERROZA BREAKS DOWN
HOW THAT RESEARCH BEGAN AND THE
ROLE THAT ANIMALS PLAYED IN
THE PROCESS.
>> TO FIND A CURE TREATMENT OR
VACCINE FOR A VIRUS. SCIENTISTS
FIRST HAVE TO UNDERSTAND HOW
THE VIRUS WORKS. WHAT DOES IT
DO HOW TO REPLICATE WHAT
HAPPENS WHEN IT INFECTS A HOST.
>> THE VERY FIRST STEP WAS
VERSUS GETTING THE VIRUS.
THEN WE HAD TO AMPLIFY
ESSENTIALLY MEANS GOING UP THE
VIRUS IN A WAY THAT WE DIDN’T
CHANGE WHAT HAPPENED TO THE
VIRUS DOCTOR RICARDO PATTY ON
JUNIOR IS A PROFESSOR AND
DIRECTOR OF MAXIMUM CONTAINMENT
RESEARCH AT TEXAS BIOMED.
>> HE WAS HIRED ON AS A
SCIENTIST AFTER RECEIVING HIS
PHD IN 2003.
>> I’VE BEEN ABLE TO
WORK AT TEXAS BIOMED IN THE
BOUT CONTAINMENT LAB THE BSA
FOR LAB AND DEVELOP NEW
PROGRAMS LOOKING AT HEMORRHAGIC
FEVER VIRUSES LIKE EBOLA LHASA
REENA VIRUSES IN
ADDITION TO NOW WORKING ON
COVID AND BSL 3.
>> HE EXPLAINED TO US THAT
AFTER THEY GREW THE VIRUS
CHARACTERIZED AND SEQUENCED IT
THE NEXT STEP WAS TO DEVELOP
ANIMAL MODELS THAT JUST MEANS
THEY FOUND A PROTOCOL IN WHICH
THEY COULD
IN A CONTROLLED FASHION INSIDE
OF A BIO CONTAINMENT LAB TRY TO
INFECT THEM WITH THE VIRUS.
>> WHEN WE FIRST ENCOUNTER THIS
NEW VIRUS. WE DIDN’T KNOW WHICH
ANIMAL MODEL WE COULD USE WE
DIDN’T KNOW WHETHER IT WOULD IN
FACT NON-HUMAN PRIMATES OR
RODENTS OR AND OTHER SPECIES.
WE HAD CLUES ONCE THEY
DETERMINED RODENTS AND
NON-HUMAN PRIMATES COULD BE
INFECTED WITH SARS COVID TOO.
>> THEY WERE ABLE TO TEST
TREATMENTS AND VACCINES.
♪
>> SO PFIZER CALLS TEXAS
BY IT AND SAID WE HAVE
A VACCINE. THIS PFIZER BIONTECH
VACCINE. IT’S AN MRNA VACCINE.
WE’VE DONE SOME WORK IN IN THAT
TISSUE CULTURE DISHES
WE NEED TO PUT IT IN ANIMALS
AND YOU KNOW HOW TO DO THAT
HUMAN.
>> TRIALS ARE REALLY GOOD THAT
BEFORE THE HUMAN TRIALS, YOU
HAVE FOR SOMETHING SAFE AND
EFFECTIVE IN HUMANS AND
ANIMALS. SO THAT WE KNOW IT’S
GOING TO BE PUT IT INTO HUMANS
AND WE STARTED
CONDUCTING RESEARCH.
>> IN THE PRIMATES BECAUSE WE
HAD ALREADY DISCOVERED THAT
THEY DEVELOP DISEASE LIKE
HUMANS AND FROM THAT RESEARCH
WE DISCOVERED THEIR VACCINE WAS
HIGHLY PROTECTED. A HIGHLY PROTECTED THE ANIMALS FROM COVID.
>> THE DATA COLLECTED FROM
ANIMAL STUDIES WAS USED TO HELP
PROVE THAT THE VACCINES WERE
SAFE ENOUGH TO BE USED IN HUMAN
CLINICAL TRIALS. >> AND RESEARCH AND PARTICULARLY NON-HUMAN PRIMATES
THE SEARCH WAS
INSTRUMENTAL NEED LICENSE SENT
OFF TO 2. IF
THE VACCINES.
>> THAT WAS DOCTOR DEEPAK
KAUSHAL THE 2 VACCINES. HE’S
REFERRING TO ARE THE PFIZER AND
THE MODERNA VACCINES. THE ONES
CREATED USING HIM
RNA TECHNOLOGY. YOU PROBABLY
HEARD MRNA USED A LOT OVER THE
COURSE OF THE PAST YEAR.
BUT THERE’S STILL SOME
CONFUSION ABOUT WHAT
EXACTLY MRNA IS AND THE ROLE IT
COULD PLAY IN THE FUTURE
VACCINES. LEXI SALAZAR
EXPLAINS.
>> YOU’VE NO DOUBT HEARD OF DNA
IT’S THE BACKBONE OF WHO WE ARE
BUT ALL HUMANS ALSO HAVE
SOMETHING CALLED MESSENGER RNA
RUNNING MRNA TAKES
DNA CODE AND CONVERTS IT TO
PROTEINS WHICH IN TURN HELPS
COMBAT DISEASE AND DEFINE OUR
BODY’S
IMMUNE SYSTEM. WE ALSO KNOW
SOME VIRUSES INCLUDING SARS
COVID TOO ALSO MORNING. JUST
AS WE HAVE MRNA TO KEEP OUR
BODIES HEALTHY. THIS VIRUS
RELIES ON MRNA TO POPULATE AND
REPRODUCE ABOUT THE EARLY
1990’S. PEOPLE HAD AN IDEA
THAT
MRNA COULD BE A DELIVERY
SYSTEM.
TO ALLOW OUR BODIES TO MAKE THE
PROTEIN FROM THE MRNA A
FOREIGN INVADERS NOT THE WHOLE
VIRUS. JUST THAT
SPECIFIC PROTEIN THAT OUR
BODIES COULD REACT. THINK OF IT
THIS WAY
MRNA IS LIKE A FACTORY, IT
HELPS THE BODY MAKE THE
PROTEINS THAT NEEDS IN THE CASE
OF COVID THE MRNA VACCINE.
ACTS LIKE VISITING FACTORY
WORKERS STOPPING BY YOUR BODY.
TEACHER OWN FACTORY,
YOUR OWN MRNA HOW TO MAKE WHAT
IT NEEDS TO PROTECT YOU AGAINST
COVID SPECIFICALLY THE MRNA
VACCINES TEACH OUR BODIES TO
MAKE THE SPIKE PROTEIN THAT
COVERS SARS COVID TOO.
SO THAT OUR IMMUNE SYSTEMS
LEARN TO RECOGNIZE IT IF EVER
WE DO BECOME INFECTED WITH THE
CORONAVIRUS THE MRNA VACCINE
FROM THE VIRUS THEN DEGRADES
OVER TIME WHICH IS HOW THE
MARKET WORKS. IT’S MADE IN THAT
IT’S DEGRADED IS DOCTOR
SCHLESINGER MENTIONED THIS
TECHNOLOGY HAS BEEN RESEARCH
FOR USE IN VACCINES SINCE THE
90’S WHEN SARS COVID 2 EMERGED,
SCIENTISTS SIMPLY PIVOTED THEY
USED EXISTING RESEARCH TO FOCUS
ON THE PANDEMIC.
>> MRNA VACCINES HAVE BEEN IN
DEVELOPMENT FOR A LONG TIME AND
FOR OTHER INFECTIONS. SO THEN
THEY’RE NOT NEW TO SCIENCE.
I THINK THE NEWS THE PUBLIC.
>> SO PFIZER AND MODERNA WITH
THE FIRST VACCINES JESUS
TECHNOLOGY, BUT THE HOPE IS
THAT IT COULD BE USED IN
THE FUTURE. PLUS INJURE SAID
IT’S ALREADY BEING LOOKED AT TO
HOPEFULLY FIND VACCINES FOR RSV
INFLUENZA. MAYBE
EVEN HIV.
>> THE KEY TO
COVID-19 IS THAT THAT ONE
PROTEIN THAT SPIKE PROTEIN HAS
BEEN SUCH AN EFFECTIVE TARGET
TO ENABLE US TO MAKE THESE
HIGHLY EFFECTIVE VACCINES.
OTHER VIRUS IS NOT
SO EASY.
>> IT’S IMPORTANT TO NOTE THAT
THE ANIMAL MODELS
CREATED BY TEXAS BIOMED WERE
ALSO USED TO TEST REGENERON’S
ANTIBODY COCKTAIL A TREATMENT
NOW WIDELY USED AND
COVID-19 PATIENTS. MOST NOTABLY
THE TREATMENT WAS USED ON
FORMER PRESIDENT DONALD TRUMP
WHEN HE CONTRACTED THE VIRUS
LAST YEAR AND RESEARCH
CONTINUES IN THEIR LABS ON
POTENTIAL VARIANTS OF THE NEXT
GENERATION OF VACCINES. AS THIS
PANDEMIC CONTINUES. THE GOAL FOR ALL OF US SINCE MARCH OF 2020 HAS BEEN TO GET THROUGH
THIS PANDEMIC BUT THE END OF
HEADLINES DOMINATED BY COVID-19
DOES NOT MEAN WE’RE NECESSARILY
DONE
WITH PANDEMICS IN FACT EVERY
SCIENTIST WE TALKED TO FOR THIS
EPISODE IS ALREADY THINKING
ABOUT THE NEXT ONE.
THEY’RE PREDICTING THAT
INFECTIOUS DISEASES WILL PLAY A
MUCH BIGGER ROLE IN OUR LIVES
THAT WE’VE EVER REALLY DON’T
WITHIN THE PAST.
AND WHAT THEY’VE LEARNED FROM
COVID-19 COULD CHANGE THINGS.
>> THE KEY IS WE MAY NOT BE SO
FORTUNATE NEXT TIME NEXT TIME
WE MAY HAVE
AN OUTBREAK OF A FEVER AND WE
DON’T KNOW WHAT IT IS
FORTUNATE MIGHT SEEM AN ODD
WORD TO USE WHEN IT COMES
TO COVID.
>> BUT ACCORDING TO RESEARCHERS
THAT’S EXACTLY WHAT
WE ARE FORTUNATE THEY ALREADY
HAD SOME FAMILIARITY WITH
CORONAVIRUS IS FORTUNATE THE
MRNA TECHNOLOGY EXISTED AND
MONEY WAS MADE AVAILABLE TO
DEVELOP A VACCINE THAT WORKS.
>> I THINK THIS IS A REALLY
EFFECTIVE AND RELATIVELY EASY
TO MANUFACTURE. IT’S A PLATFORM
FOR VACCINES FOR THE FUTURE.
SO I THINK IT’S A GAME CHANGER.
>> AND CHANGES, WE’LL CERTAINLY
HAVE TO BE MADE. HE SAYS
HOW THE NEXT VACCINE IS
FORMULATED TO FIGHT THE NEXT
VIRUS. THAT’S DISCOVERED IS AN
UNKNOWN, IT’S LESS INJURE SAYS
EVERY YEAR ABOUT 15 TO 20 NEW
VIRUSES ARE
UNCOVERED WORLDWIDE. WHILE
COVID-19 IS NO LONGER KNEW WE
ARE STILL LEARNING
ABOUT IT WHY THERE ARE
SO-CALLED COVID LONGHAULERS THE
PEOPLE WHO LIVE WITH SYMPTOMS
MONTHS AFTER BEING INFECTED.
WHY SOME PEOPLE FARE FAR BETTER
WITH COVID THAN OTHERS
LEARNING MORE ABOUT THE IMMUNE
SYSTEM WILL BE KEY.
>> WE EXPECT THAT INFECTIOUS
DISEASES IN THE NEXT 30 YEARS
WOULD BECOME THE MOST
>> FROM OFF HUMAN
IN IT.
>> ANOTHER CHANGE THESE
RESEARCHERS HOPE TO WORK ON MAY
NOT BE THE RESULT OF ANY
CLINICAL TRIAL. THEY’D LIKE TO
SEE CLEARER STRAIGHTFORWARD
COMMUNICATION ABOUT SCIENCE
MAKE IT MORE APPROACHABLE
ESPECIALLY WHEN IT COMES TO
VACCINES.
>> MANY SCIENTISTS HAVE BEEN
TALKING TO THE PUBLIC AND
EXPLAINING HOW IT WORKS.
♪
AND I THINK THAT
WAS MISSING. THE SCIENTISTS WE
DON’T ALWAYS. A COMMUNIQUE A
SCIENCE WELL TO
♪
THE PUBLIC AND I THINK.
HAS TO CHANGE AND I THINK THIS
HAS BEEN A PART OF THAT PROCESS
OF IT CHANGING THE SIDE EFFECT
THAT I’VE SEEN
IS THAT.
>> THERE ARE MANY PEOPLE THAT
ARE SPEAKING THE AUTHORITATIVE
LEE THAT THEY
DON’T UNDERSTAND THE CONCEPT
AND THAT THAT CAN BE A LITTLE
DANGEROUS I THINK WHAT THAT
TRANSLATES INTO ADULTS AND THE
PUBLIC IS.
>> NOT FEAR, BUT
A HESITANCY AND THAT LEADS US
THIS IDEA THAT THERE’S THIS
MYSTERY BEHIND WHAT’S HOT IN
THIS PLOT TALKS OF WHAT OCCURS
AND THIS. A SCIENTIST SAYS
SCIENCE IS FOR
THE SUPER ELITE OR THE SUPER
SMART AND WHATEVER AND NONE OF
THAT IS TRUE SCIENCE IS ABOUT
DISCOVERY
AND EXPLORATION. I MEAN ASKING
QUESTIONS PERHAPS THE BIGGEST
QUESTION IN FRONT OF ALL OF US
NOW IS WHEN WILL THIS PANDEMIC
END.
>> THINGS SEEM TO BE RETURNING
TO NORMAL IN 2021. THEN THE
DELTA VARIANT ARRIVED
THE MORE COVID SPREADS THE MORE
IT MUTATES IF WE CAN STOP THE
VIRUS BEING IN US.
♪
♪
♪ ♪ >> NOT TRANSMIT IT TO OTHERS WE
CAN SOME VARIANTS. IT’S REALLY
THAT SIMPLE
SO TO HAVE LESS VIRUS IN THE
POPULATION, WE NEED PEOPLE TO
VACCINATE.
WELL TO BE DISTANCING
THEMSELVES AND NOT TRANSMIT
THING AND GETTING SICK. SO
EVERY TIME.
THERE’S A CHANCE WE’LL HAVE A
NEW VARIANT.
9 TIMES AT THE TIME THAT NEW
VARIANT IS NOT ANY WORSE THAN
THE MOMENT.
MAYBE ONCE AND WE’RE GOING TO
SEE ONE IS.
>> A SOLUTION RELYING ON
SCIENCE AND
HUMAN BEHAVIOR. TEXAS BY OF
THAT IS RELYING ON THE WAYS
IT’S HAD TO ADAPT BECAUSE OF
COVID-19 AND THE LESSONS
LEARNED HERE TO SHAPE THE ROLE
IT WILL PLAY DURING THE NEXT
OUTBREAK IF.
>> THERE WAS TO BE ANOTHER
PANDEMIC SO WHEN I THINK THAT
IT’S POSSIBLE TO BE BETTER.
A
SYSTEM RIGHT NATIONWIDE AND AND
I THINK WHY I THINK THE FUTURE.
>> WILL BE A
VERY DIFFERENT TYPE OF VISION
FROM MY PERSPECTIVE WHERE
ORGANIZATIONS LIKE TEXAS PRIME
IT CAN PARTICIPATE IN A MUCH
MORE PROACTIVE SUSTAINABLE WAY
TO HELP AVERT THESE PANDEMICS
WHICH WILL OCCUR AGAIN IN THE
FUTURE.
♪
>> JUST AS WE’VE DONE FOR THE PAST 19 MONTHS WILL CONTINUE TO BRING YOU THE LATEST NEWS ABOUT
THE PANDEMIC AND ANY SCIENTIFIC
BREAKTHROUGHS MEANT TO ADDRESS
IT.
♪
IT. ♪ THANKS FOR JOINING US FOR THIS
EPISODE OF KSAT EXPLAINS WE’LL
SEE YOU NEXT TIME.